EUVIMEDEUVIMED entdecken
Crossref

Bergenin as an antidiabetic agent: From molecular pathway to therapeutic potential

Ghanshyam Mapare, Sateesh Belemkar

Obesity Medicine · 2026-07 · 62 · 100718

DOI: 10.1016/j.obmed.2026.100718 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity Medicine, 2026-07. Verfasst von Ghanshyam Mapare und 1 weiteren Autor:innen. Die Arbeit nennt 60 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Mapare, G., & Belemkar, S. (2026). Bergenin as an antidiabetic agent: From molecular pathway to therapeutic potential. Obesity Medicine, 62, 100718. https://doi.org/10.1016/j.obmed.2026.100718

Vancouver

Mapare G, Belemkar S. Bergenin as an antidiabetic agent: From molecular pathway to therapeutic potential. Obesity Medicine. 2026;62:100718. doi:10.1016/j.obmed.2026.100718

BibTeX
@article{Mapare2026,
  author = {Mapare, Ghanshyam and Belemkar, Sateesh},
  title = {Bergenin as an antidiabetic agent: From molecular pathway to therapeutic potential},
  journal = {Obesity Medicine},
  year = {2026},
  volume = {62},
  pages = {100718},
  doi = {10.1016/j.obmed.2026.100718}
}
Kostenlos starten →